↓ Skip to main content

Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours

Overview of attention for article published in Breast Cancer Research, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
8 news outlets
twitter
7 X users
facebook
1 Facebook page

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
56 Mendeley
Title
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours
Published in
Breast Cancer Research, January 2019
DOI 10.1186/s13058-018-1089-5
Pubmed ID
Authors

Cigdem Selli, Arran K. Turnbull, Dominic A. Pearce, Ang Li, Anu Fernando, Jimi Wills, Lorna Renshaw, Jeremy S. Thomas, J. Michael Dixon, Andrew H. Sims

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 18%
Student > Ph. D. Student 9 16%
Student > Master 5 9%
Student > Bachelor 4 7%
Student > Doctoral Student 4 7%
Other 8 14%
Unknown 16 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 23%
Medicine and Dentistry 11 20%
Agricultural and Biological Sciences 4 7%
Nursing and Health Professions 2 4%
Immunology and Microbiology 1 2%
Other 9 16%
Unknown 16 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 65. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2019.
All research outputs
#655,528
of 25,385,509 outputs
Outputs from Breast Cancer Research
#55
of 2,054 outputs
Outputs of similar age
#15,064
of 444,976 outputs
Outputs of similar age from Breast Cancer Research
#1
of 38 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,976 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.